Rupa Rajbhandari Singh

Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance

Suman Rijal, Bart Ostyn, Surendra Uranw et al. · Clinical Infectious Diseases · 2013 · 314 citations · Full text

Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline

S Rijal, François Chappuis, Rupa Rajbhandari Singh et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2003 · 123 citations

South-eastern Nepal, Parasitic Protozoa, Malaria +8

Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?

Suman Rijal, Vanessa Yardley, François Chappuis et al. · Microbes and Infection · 2007 · 97 citations

Antiparasitic Agent, Parasitic Protozoa, Immunology +7

Evaluation of a urinary antigen‐based latex agglutination test in the diagnosis of kala‐azar in eastern Nepal

Suman Rijal, Marleen Boelaert, Sudhir Regmi et al. · Tropical Medicine & International Health · 2004 · 80 citations

Epidemiological dynamics of antimonial resistance in Leishmania donovani: Genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from Nepal

Thierry Laurent, Suman Rijal, Vanessa Yardley et al. · Infection Genetics and Evolution · 2006 · 71 citations

Disease Resistance, Leishmania Donovani, Antimonial Resistance +8